Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis
about
Tackling tuberculosis: Insights from an international TB Summit in LondonDaily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.Tuberculosis (HIV-negative people).The pyrazinamide susceptibility breakpoint above which combination therapy fails.Intermittent Versus Daily Pulmonary Tuberculosis Treatment Regimens: A Meta-Analysis.Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives.Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice.Chemotherapeutic interventions against tuberculosisPharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.Genotyping and Prevalence of Pyrazinamide- and Moxifloxacin-Resistant Tuberculosis in China, 2000 to 2010.Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals.Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used.Tuberculosis (HIV-negative people)
P2860
Q28602294-8FA1DB2B-DA08-4584-A1C2-D6F59C9C9392Q33735589-E674BD7D-7C9B-4355-A067-C1660D9175B8Q33843941-2691DFC0-C2AA-466C-A890-B56977E064BAQ34034401-13AC7DC6-05F1-4B06-95F1-59C83D626EF7Q35657670-8E18207D-3E73-49BC-B201-24711CC3EF68Q35743972-FCB84D1C-D147-40A4-97D8-AACEABC5D997Q36921509-CCDAF3E6-F596-4139-833A-F007D319E3DEQ37148764-933E1DF1-50F5-4606-AB8B-72820D35F52EQ37274688-351DC452-2684-4D01-834A-05CDD00FF797Q37339276-4A7E8184-C13A-4BEF-8236-5D78B604DED5Q37612926-035BFABE-A44A-4E83-9CEA-B65D3F79219DQ40139981-0B53E8EB-26D0-43A1-A574-BE4327E8DAE9Q41221781-06DD34C1-3C3B-44A9-955A-234C75027DF9Q42111332-DE270A31-2F55-4CCD-B02F-2E5A23837D76Q56836949-113A7252-C675-4B70-AC9D-A875242AD294
P2860
Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis
description
1981 nî lūn-bûn
@nan
1981 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@ast
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@en
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@nl
type
label
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@ast
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@en
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@nl
prefLabel
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@ast
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@en
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@nl
P3181
P1433
P1476
Controlled trial of four thric ...... ths for pulmonary tuberculosis
@en
P3181
P356
10.1016/S0140-6736(81)90057-X
P407
P577
1981-01-24T00:00:00Z